The Association Between Hypothyroidism Treatment and Mortality in Patients Hospitalized in Surgical Wards

Hiba Masri-Iraqi, Yaron Rudman, Carmel Friedrich Dubinchik, Idit Dotan, Talia Diker-Cohen, Liat Sasson, Tzipora Shochat, Ilan Shimon, Eyal Robenshtok, Amit Akirov*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Limited data are available regarding the association between pre-admission thyroid-stimulating hormone (TSH) levels and prognosis in hospitalized surgical patients treated for hypothyroidism. We retrospectively evaluated a cohort of 1,451 levothyroxine-treated patients, hospitalized to general surgery wards. The 30-day mortality risk was 2-fold higher for patients with TSH of 5.0–10.0 mIU/L (adjusted OR, 2.3; 95% CI 1.1–5.1), and 3-fold higher for those with TSH > 10.0 mIU/L (3.4; 95% CI 1.3–8.7). Long-term mortality risk was higher in patients with TSH of 5.0–10.0 and above 10.0 mIU/L (adjusted HR, 1.2; 95% CI, 1.0–1.6, and 1.7; 95% CI 1.2–2.4, respectively). We found that in levothyroxine-treated adults hospitalized to surgical wards, increased pre-admission TSH levels are associated with increased short- and long-term mortality.

Original languageEnglish
Pages (from-to)68-76
Number of pages9
JournalEndocrine Research
Volume48
Issue number2-3
DOIs
StatePublished - 2023

Keywords

  • Hypothyroidism
  • mortality
  • surgery
  • thyroid replacement therapy

Fingerprint

Dive into the research topics of 'The Association Between Hypothyroidism Treatment and Mortality in Patients Hospitalized in Surgical Wards'. Together they form a unique fingerprint.

Cite this